Comorbid alcohol dependence is common in patients with schizophrenia and is associated with a variety of serious adverse consequences. Although case reports exist concerning the positive impact oflamotrigine addition on clozapine treatment in resistant schizophrenia, a review of the literature fails to document any evidence regarding acombination of the two in the treatment of patients with schizophrenia and comorbid alcohol dependence. In the present study, we present three cases in which patients with resistant schizophrenia and comorbid alcohol use disorder were given lamotrigine to augment clozapine. Our findings suggest that clozapine plus lamotrigine may be helpful inreducing alcohol consumption and craving among patients with schizophrenia and comorbid alcohol dependence.
Albanese M J , Khantzian E J , Murphy S L , Green A I (1994) Decreased substance use in chronically psychotic patients treated with clozapine . Am J Psychiatry151: 780–781
2.
Amer1can Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn.The American Psychiatric Association, Washington, DC
3.
Buckley R , Thompson P , Way L , Meltzer H Y (1994) Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy . Am J Psychiatry151: 385–389
4.
Chouljian T L , Shumway M I , Balancio E , Dwyer E V , Surber R , Jacobs M (1995) Substance use among schizophrenic outpatients: prevalence, course, and relation to functional status . Annal Clin Psychiatry7: 19–24
5.
Conley R R , Buchanan R W (1997) Evaluation of treatment-resistant schizophrenia . Schizophr Bull23: 663–674
6.
Cournos F , Empfield M , Horwath E , McKinnon K , Meyer L , Schrage H , Currie C , Agosin B (1991) HIV seroprevalence among patients admitted to two psychiatric hospitals . Am J Psychiatry148: 1225–1230
7.
Cuffel B J , Shumway M , Chouljian T L , MacDonald T (1994) A longitudinal study of substance abuse and community violence in schizophrenia . J Nerv Ment Dis182: 704–708
8.
Dursun S M , McIntosh D , Milliken H (1999) Clozapine plus lamotrigine in treatment-resistant schizophrenia . Arch Gen Psychiatry56: 950–950
9.
Dursun S M , Deakin J F (2001) Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study . J Psychopharmacol15: 297–301
10.
Drake R E , Osher F C , Wallach M A (1989) Alcohol use and abuse in schizophrenia . A prospective community study. J Nerv Ment Dis177: 408–414
11.
Drake R E , Antosca L M , Noordsy D L , Bartels S J , Osher F C (1991) New Hampshire’s specialized services for the dually diagnosed . New Dir Ment Health Serv50: 57–67 .
12.
Drake R E , Xie H , McHugo G J , Green A I (2000) The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia . Schizophr Bull26: 441–449
13.
Elwers R D , Binnie C D (1996) Clinical pharmacokinetics of newer antiepileptic drugs: lamotrigine, vigabatrin, gabapentin, and oxcarbazepine . Clin Pharmacokinet30: 403–415
14.
Kalyoncu A , M1rsal H , Pektaş Ö , Şatir T , Serez M , Beyazyürek M (2000) A new treatment model for inpatient alcoholics . Journal of Dependence (Turkish)1: 27–31
15.
Kossen M , Selten J P , Kahn R S (2001) Elevated clozapine plasma level with lamotrigine . Am J Psychiatry158: 1930–1930
16.
Litten R Z , Allen J , Fertig J (1996) Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991 . Alcohol Clin Exp Res20: 859–876
17.
Richelson E (1996) Preclinical pharmacology of neuroleptics: Focus on new generation compounds . J Clin Psychiatry57 (Suppl 11): 4–11
18.
Regier D A , Farmer M E , Rae D S , Locke B Z , Keith S J , Judd L , Goodwin R (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study . JAMA264: 2511–2518
19.
Saba G , Dumortier G , Kalalou K , Benadhira R , Degrassat K , Glikman J , Januel D (2002) Lamotrigine-clozapine combination in refractory schizophrenia: three cases . J Neuropsychiatry Clin Neurosci14: 86–86
20.
Swofford C D , Kasckow J W , Scheller-Gilkey G , Inderbitzin L B (1996) Substance abuse: a powerful predictor of relapse in schizophrenia . Schizophr Res20: 145–151
21.
Tiihonen J , Hallikainen T , Ryynanen OP , Repo-Tiihonen E , Kotilainen I , Eronen M , Toivonen P , Wahlbeck K , Putkonen A (2003) Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial . Biol Psychiatry54: 1241–1248
22.
Wagstaff J , Bryson H M (1990) Clozapine . Drugs40: 722–747
23.
Xie X , Hagan R M (1998) Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder . Neuropsycho-biology38: 119–130
24.
Zimmet S V , Strous R D , Burgess E S , Kohnstamm S , Green A I (2000) Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey . J Clin Psycho-pharmacol20: 94–98
